Device Trial Radar · NCT02373540
Algovita Post-Market Clinical Study: Spinal Cord Stimulation to Treat Chronic Pain
Last checked: Nov 20, 2026Latest source record: Aug 21, 2020 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Terminated
Enrollment
91
Actual
Start
Jun 2015
Primary completion
Nov 2019
Study completion Nov 2019
Sponsor
- Lead sponsor
- NuvectraNot on our public-company list
- Sponsor type
- Industry
- Collaborators
- Bright Research Partners
- First posted
- Feb 27, 2015
Design
- Study type
- Observational
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to obtain real-world clinical outcome data for the Algovita Spinal Cord Stimulation system when used, on-label, according to the applicable directions for use.
Conditions
- Chronic Pain
Interventions
Algovita Spinal Cord Stimulation systemDevice
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percent reduction in targeted pain compared to baselineTime frame: 6 Month Follow-up Visit
Locations
18 sites in 2 countries. Site status is shown where the registry gives one.
Summit Healthcare Pain Clinic Associates
Show Low, Arizona
Coastal Pain and Spinal Diagnostics
Carlsbad, California
Samaritan Center for Medical Research
Los Gatos, California
15 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.